AC Immune SA ACIU
- ACI-24.060 — Alzheimer's Disease Phase 2
- ACI-24.060 — Alzheimer's Disease in Down Syndrome Phase 2
- crenezumab — Alzheimer's Disease
amyloid beta (1 companies · 3 programs)
Companies with an active program directed at amyloid beta.
Companies with an active program directed at amyloid beta.